Fundraising Fox
Fusion Pharmaceuticals
Founded 2014 · 60 employees on LinkedIn · 18 known investors
Find your way into Fusion Pharmaceuticals
Sign up to see every warm intro you have to Fusion Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fusion Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells. A spin-out of the Centre for Probe Development and Commercialization, it focuses on radiopharmaceuticals for cancer treatment.
Founders & leadership
Fusion Pharmaceuticals was founded in 2014 by John Valliant.
Investors · 18
How we know: FACIT (Fight Against Cancer Innovation Trust)'s portfolio page · Not right? Tell us
How we know: HealthCap's portfolio page · healthcap.eu · Not right? Tell us
How we know: Lumira Ventures's portfolio page · Not right? Tell us
How we know: Pivotal Life Sciences's portfolio page · healthcap.eu · Not right? Tell us
How we know: a partner's Signal profile · healthcap.eu · Not right? Tell us
How we know: Venture Ontario's portfolio page · Not right? Tell us
How we know: Ysios Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · healthcap.eu · Not right? Tell us
How we know: funding news · healthcap.eu · Not right? Tell us
How we know: funding news · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements$20M disclosed across 1 of 4 rounds · 2017–2020
- $20MraisedJan 2020 · 2 sources
Canada Pension Plan Investment Board
Source ↗ - Undisclosed amountSeries BApr 2019
OrbiMed (lead), Varian (lead), Adams Street Partners, FACIT, Genesys Capital, Healthcap, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Perceptive Advisors, Pivotal bioVenture Partners, Rock Springs Capital, Seroba Life Sciences, TPG Biotech
Source ↗ - Undisclosed amountSeries ASep 2017Source ↗
- Undisclosed amountSeries AFeb 2017
Johnson & Johnson Innovation (lead), FACIT, Genesys Capital, HealthCap, TPG Biotech
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Fusion Pharmaceuticals went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Fusion Pharmaceuticals.
In the news
Frequently asked questions
- What does Fusion Pharmaceuticals do?
- Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells. A spin-out of the Centre for Probe Development and Commercialization, it focuses on radiopharmaceuticals for cancer treatment.
- Who founded Fusion Pharmaceuticals?
- Fusion Pharmaceuticals was founded by John Valliant in 2014.
- Who are Fusion Pharmaceuticals's investors?
- Fusion Pharmaceuticals's investors include FACIT (Fight Against Cancer Innovation Trust), HealthCap, Lumira Ventures, Pivotal Life Sciences, Seroba Life Sciences, Venture Ontario, Ysios Capital, Adams Street Partners and 5 more.
- How much funding has Fusion Pharmaceuticals raised?
- Fusion Pharmaceuticals has disclosed $20M raised across 1 of its 4 known rounds.